Top Markets
Coin of the day
Sartorius Aktiengesellschaft Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

SOAGY
Classement en actions #317
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and... Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. The company offers biosensors and kits, compliance tools, systems software, label-free detection systems, and SPR systems; live-cell analysis systems, flow cytometry platform, and cell analysis reagents and consumables; and antibody and recombinant protein media, viral vaccines media, regenerative medicine media, general media, downstream buffer, microcarrier, and stem cell media and reagent products, as well as strong acids, bases, and alcohols and detergents. It also provides multi-parallel bioreactors, benchtop bioreactors, single-use bioreactors, stainless steel bioreactors, cell culture bioreactors, microbial bioreactors, and software apps for bioreactors; membranes, blotting products, filter papers, glass and quartz microfibre products, and filtration equipment; syringe filters; and filtration devices, ultrafiltration devices, sterile filtration devices, harvesting devices, analytical sample prep systems, buffer exchange systems, diagnostic sample prep systems, particle analysis systems, pharmaceutical filtration systems, protein DNA concentration systems, venting moisture barriers, clarification systems, buffer and media products, and membrane chromatography products. In addition, the company offers process filtration products; process filtration products; process chromatography products; fluid management products; process analytical technology and data analytics; industrial microbiology systems; water purification systems; weighing systems; pipetting and dispensing systems; OEM systems; and centrifuges. Further, it provides bioprocess development and engineering, protein expression system, media and process, testing, instrument, and validation services. It serves the life science research, biopharmaceutical manufacturing, quality control and testing, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.
Prix de l'action
$47.54
Capitalisation boursière
$69.46B
Changement (1 jour)
-3.59%
Changement (1 an)
-9.07%
Pays
DE
Échange Sartorius Aktiengesellschaft (SOAGY)

Catégorie

Bénéfices pour Sartorius Aktiengesellschaft (SOAGY)
Bénéfices en Dec 2025 TTM : $394.38M
Selon les derniers rapports financiers de Sartorius Aktiengesellschaft, les bénéfices actuels de l'entreprise sont de $394.38M. En 2023, l'entreprise a réalisé un bénéfice de $426.71M, une diminution par rapport à celui de 2022 qui était de $1.27B. Les bénéfices affichés sur cette page correspondent aux bénéfices avant intérêts et impôts, appelés aussi EBIT.
Historique des bénéfices pour Sartorius Aktiengesellschaft de 2002 à 2026
Bénéfices à la fin de chaque année
Année Bénéfices Changez
2026 (TTM) $394.38M 102.89%
2024 $194.38M -54.45%
2023 $426.71M -66.34%
2022 $1.27B 66.77%
2021 $760.07M 46.93%
2020 $517.29M 52.17%
2019 $339.95M 9.28%
2018 $311.07M 28.86%
2017 $241.40M 12.41%
2016 $214.76M 14.73%
2015 $187.18M 60.76%
2014 $116.43M -11.24%
2013 $131.18M 5.88%
2012 $123.90M 21.09%
2011 $102.33M 22.03%
2010 $83.85M 469.25%
2009 $14.73M -60.63%
2008 $37.42M -37.89%
2007 $60.25M -0.18%
2006 $60.35M 45.20%
2005 $41.57M 10.05%
2004 $37.77M 214.76%
2003 $12.00M 52.12%
2002 $7.89M 0.00%
Bénéfices des entreprises similaires ou concurrentes
Entreprise Bénéfices Différence de bénéfices Pays
$3.31B 739.65%
US
$2.06B 423.10%
US
$2.05B 418.94%
JP
$1.16B 194.13%
CH
$1.82B 361.15%
US